Bumper Offer - Urjas oil Just @ Rs. 1
S Vocita Tablet is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Depression. Secondary and off-label uses of S Vocita Tablet have also been mentioned below.
The right dosage of S Vocita Tablet depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of S Vocita Tablet as well, which are listed below. Normally, these side effects of S Vocita Tablet are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, S Vocita Tablet's effect is Moderate during pregnancy and Severe for lactating mothers. It is important to know if S Vocita Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the S Vocita Tablet related warnings section.
The section on S Vocita Tablet contraindications lists all such conditions.
Drug reaction of S Vocita Tablet with other medicines has been reported. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking S Vocita Tablet is considered not safe while driving, and is not addictive.
S Vocita Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Adult(Male) |
|
| Geriatric |
|
Based on research, the following side effects have been observed when S Vocita Tablet is used -
Moderate
Mild
Is the use of S Vocita Tablet safe for pregnant women?
S Vocita can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking S Vocita right away. Take your doctor's advice before taking it again.
Is the use of S Vocita Tablet safe during breastfeeding?
Taking S Vocita may lead to serious side effects if you are breastfeeding. S Vocita should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of S Vocita Tablet on the Kidneys?
S Vocita rarely harms the kidneys.
What is the effect of S Vocita Tablet on the Liver?
S Vocita is rarely harmful for the liver.
What is the effect of S Vocita Tablet on the Heart?
S Vocita is rarely harmful for the heart.
S Vocita Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take S Vocita Tablet unless your doctor advises you to do so -
Is this S Vocita Tablet habit forming or addictive?
No, you will not get addicted to S Vocita Tablet.
Is it safe to drive or operate heavy machinery when consuming?
After taking S Vocita Tablet, you should not drive or work on any heavy machine, as S Vocita Tablet can make you drowsy.
Is it safe?
S Vocita Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
S Vocita Tablet has been seen to have positive effect on patients with mental disorders.
Interaction between Food and S Vocita Tablet
Taking S Vocita Tablet with food does not cause any problems.
Interaction between Alcohol and S Vocita Tablet
Consumption of alcohol and S Vocita Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522